脓毒症患者免疫指标与预后的关系:基于MIMIC-IV数据库的数据分析
基于美国MIMIC-IV v2.0数据库2008至2019年住院资料,纳入33 745例患者(脓毒症1 509例,非脓毒症32 236例),比较免疫指标与28天预后。脓毒症组入ICU 3天和7天内CD3、CD8计数显著低于非脓毒症组,IgA水平显著高于非脓毒症组;脓毒症存活组CD3、CD4计数及CD4/CD8比值显著高于死亡组。CD4/CD8比值预测脓毒症28天预后的AUC为0.615(95%CI 0.555-0.671),敏感度70.83%,特异度52.49%。作者认为早期CD4/CD8指标可在一定程度上预测脓毒症预后。
要点
- 脓毒症患者入ICU 3天内CD4/CD8比值存活组1.87±0.80 vs 死亡组1.02±0.12,7天内1.88±0.79 vs 1.03±0.13,均P<0.05。
- 入ICU 3天内CD4/CD8比值预测脓毒症28天预后AUC 0.615(95%CI 0.555-0.671),敏感度70.83%,特异度52.49%。
- 脓毒症组入ICU 3天和7天内CD3计数均显著低于非脓毒症组(3天:(1 080.74±849.23)/μL vs (1 242.91±889.24)/μL,7天:(1 079.69±850.61)/μL vs (1 242.48±889.23)/μL,均P<0.05)。
- 脓毒症组高血压、糖尿病、冠心病比例显著高于非脓毒症组(高血压10.07% vs 2.47%,糖尿病50.10% vs 15.18%,冠心病31.21% vs 19.19%,均P<0.05)。
- 脓毒症组入ICU 3天和7天内IgA水平显著高于非脓毒症组(3天:(275.01±216.96) mg/L vs (85.99±75.76) mg/L,7天数值相同,均P<0.05)。
适用人群与场景
- 基于MIMIC-IV v2.0数据库2008至2019年住院患者,纳入33 745例,其中脓毒症1 509例,非脓毒症32 236例。
- 收集的变量包括CD3计数、CD4计数、CD8计数、CD4/CD8比值、免疫球蛋白(IgA、IgG、IgM)水平、淋巴细胞计数、性别、年龄、体重指数(BMI)、序贯器官衰竭评估(SOFA)评分、冠心病、高血压、糖尿病、基础疾病及28天预后。
研究设计与关键结果
- 研究类型为基于MIMIC-IV v2.0数据库的数据分析,纳入2008至2019年住院患者33 745例,其中脓毒症1 509例(28天内存活1 084例,死亡425例),非脓毒症32 236例。
- 脓毒症组入ICU 3天和7天内CD3计数、CD8计数均显著低于非脓毒症组(3天:CD3 (1 080.74±849.23)/μL vs (1 242.91±889.24)/μL,CD8 (558.07±368.77)/μL vs (625.07±529.66)/μL;7天:CD3 (1 079.69±850.61)/μL vs (1 242.48±889.23)/μL,CD8 (556.70±467.23)/μL vs (624.93±429.78)/μL,均P<0.05)。
- 脓毒症组BMI(kg/m²:33.25±28.71 vs 28.90±15.28)及入ICU 3天和7天内IgA水平均显著高于非脓毒症组(3天:(275.01±216.96) mg/L vs (85.99±75.76) mg/L;7天:(275.01±216.96) mg/L vs (85.99±75.76) mg/L,均P<0.05)。
- 脓毒症组高血压、糖尿病、冠心病比例显著高于非脓毒症组(高血压:10.07%(152/1 509)vs 2.47%(796/32 236);糖尿病:50.10%(756/1 509)vs 15.18%(4 895/32 236);冠心病:31.21%(471/1 509)vs 19.19%(6 186/32 236),均P<0.05)。
- 脓毒症存活组入ICU 3天和7天内CD3计数、CD4计数及CD4/CD8比值均显著高于死亡组(3天:CD3 (1 127.20±857.14)/μL vs (938.26±810.50)/μL,CD4 (559.76±507.18)/μL vs (338.75±267.11)/μL,CD4/CD8比值1.87±0.80 vs 1.02±0.12;7天:CD3 (1 124.01±810.53)/μL vs (943.78±808.21)/μL,CD4 (559.56±507.36)/μL vs (341.95±266.56)/μL,CD4/CD8比值1.88±0.79 vs 1.03±0.13,均P<0.05)。
- 入ICU 3天内CD4/CD8比值预测脓毒症28天预后的ROC曲线下面积(AUC)为0.615(95%CI 0.555-0.671),敏感度70.83%,特异度52.49%。
证据类型、等级与局限
- 证据类型:基于MIMIC-IV v2.0数据库的数据分析(观察性研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为高血压、冠心病、糖尿病更易诱发脓毒症;脓毒症患者免疫指标在早期即发生变化;早期CD4/CD8指标可在一定程度上预测脓毒症患者预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the relationship between the changes of immune indexes and prognosis in patients with sepsis.
METHODS: Based on the hospitalization information from 2008 to 2019 in the American Medical Information Mart for Intensive Care-IV v2.0 (MIMIC-IV v2.0), the hospitalized data including CD3 count, CD4 count, CD8 count, CD4/CD8 ratio, immunoglobulins (IgA, IgG, IgM) levels and lymphocyte counts, gender, age, body mass index (BMI), sequential organ failure assessment (SOFA), and prognosis of patients with coronary heart disease, hypertension, diabetes mellitus, underlying diseases, and 28-day prognosis were collected. The immunological indexes affecting the prognosis of patients with sepsis were compared and analyzed. The receiver operator characteristic curve (ROC curve) was drawn to analyze the value of immunological indexes in predicting the 28-day prognosis of patients with sepsis.
RESULTS: A total of 33 745 patients were enrolled in the study, including 1 509 cases of sepsis and 32 236 cases without sepsis. Among the patients with sepsis, there were 1 084 cases alive and 425 cases died within 28 days. BMI (kg/m2: 33.25±28.71 vs. 28.90±15.28) and IgA levels within 3 days and 7 days after admission in sepsis group were significantly higher than those in the non-sepsis group [within 3 days after admission: (275.01±216.96) mg/L vs. (85.99±75.76) mg/L; within 7 days after admission: (275.01±216.96) mg/L vs. (85.99±75.76) mg/L, all P < 0.05]. CD3 count, CD8 count within 3 days and 7 days after admission in sepsis group were significantly lower than that in the non-sepsis group [within 3 days after admission: CD3 counts were (1 080.74±849.23)/μL vs. (1 242.91±889.24)/μL, CD8 counts were (558.07±368.77)/μL vs. (625.07±529.66)/μL; within 7 days after admission: CD3 counts were (1 079.69±850.61)/μL vs. (1 242.48±889.23)/μL, CD8 counts were (556.70±467.23)/μL vs. (624.93±429.78)/μL, all P < 0.05]. The proportion of patients with hypertension, diabetes and coronary heart disease were significantly higher than those in the non-sepsis group [hypertension: 10.07% (152/1 509) vs. 2.47% (796/32 236), diabetes: 50.10% (756/1 509) vs.15.18% (4 895/32 236), coronary heart disease: 31.21% (471/1 509) vs. 19.19% (6 186/32 236), all P < 0.05]. In the sepsis group, the CD3 count, CD4 count and CD4/CD8 ratio in the survival group were significantly higher than those in the death group within 3 days and 7 days after admission [within 3 days after admission: CD3 counts were (1 127.20±857.14)/μL vs. (938.26±810.50)/μL, CD4 counts were (559.76±507.18)/μL vs. (338.75±267.11)/μL, CD4/CD8 ratios were 1.87±0.80 vs. 1.02±0.12; within 7 days after admission: CD3 count were (1 124.01±810.53)/μL vs. (943.78±808.21)/μL, CD4 count were (559.56±507.36)/μL vs. (341.95±266.56)/μL, CD4/CD8 ratios were 1.88±0.79 vs. 1.03±0.13, all P < 0.05]. The area under the ROC curve (AUC) of CD4/CD8 ratio within 3 days after admission in predicting the prognosis of septic patients at 28 days was 0.615 [95% confidence interval (95%CI) was 0.555-0.671], the sensitivity was 70.83%, and the specificity was 52.49%.
CONCLUSIONS: Hypertension, coronary heart disease and diabetes are more likely to induce sepsis. The changes of immune indexes in patients with sepsis will occur in the early stage. Early CD4/CD8 index can predict the prognosis of patients with sepsis to a certain extent.
参考来源
- Wang J, Zhang Y, Gao Y, et al. [Relationship between immune indexes and prognosis in patients with sepsis: data analysis based on MIMIC-IV database]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36377446. doi:10.3760/cma.j.cn121430-20211102-01622
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。